BioSpace News Archive

Press Releases

Sensient Declares Dividend - October 24, 2024

October 25, 2024
·
1 min read
Press Releases

Qurient Launches Clinical Trial for Acute Myeloid Leukemia Treatment with Adrixetinib (Q702)

October 25, 2024
·
2 min read
Press Releases

Septerna Prices Upsized Initial Public Offering

October 25, 2024
·
4 min read
Press Releases

Agomab Announces $89 Million Series D Financing to Support Broad Fibrosis-Focused Pipeline

October 25, 2024
·
2 min read
Press Releases

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance

October 25, 2024
·
3 min read
Press Releases

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of Livers Awaiting Transplantation

October 25, 2024
·
3 min read
Press Releases

Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD).

October 25, 2024
·
3 min read
Press Releases

Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma

October 25, 2024
·
7 min read
Press Releases

Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium

October 25, 2024
·
2 min read
Press Releases

Egle Therapeutics to Share Preclinical Efficacy Data for EGL-001, a CTLA-4/CD25 Antagonist Fusion Protein at the Society for Immunotherapy of Cancer Meeting

October 25, 2024
·
2 min read